Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer.
Authors
Bernstein, Jonathan MKershaw, Lucy E
Withey, Stephanie B
Lowe, Natalie M
Homer, Jarrod J
Slevin, Nicholas J
Bonington, Suzanne C
Carrington, Bernadette M
West, Catharine M L
Affiliation
University Department of Otolaryngology - Head & Neck Surgery, Manchester Academic Health Science Centre, University of Manchester.Issue Date
2015-02-17
Metadata
Show full item recordAbstract
Non-response to induction chemotherapy (IC) occurs in 30% of head and neck squamous cell carcinoma (HNSCC) and has been predicted by tumor plasma flow (Fp) derived by perfusion computed tomography. The present study was designed to test whether baseline tumor Fp determined by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) would predict IC response.Citation
Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer. 2015: Oral OncolJournal
Oral OncologyDOI
10.1016/j.oraloncology.2015.01.013PubMed ID
25700703Type
ArticleLanguage
enISSN
1879-0593ae974a485f413a2113503eed53cd6c53
10.1016/j.oraloncology.2015.01.013